semaglutide eye rot A new study suggests patients taking — the active ingredient in Ozempic and Wegovy — may be at higher risk of developing an condition that can cause blindness. Non-arteritic anterior Semaglutide Linked to Increased Risk

A 10-minute review of a vendor COA, testing history, and community reputation can save you hundreds in wasted peptide

There was a small increase in exposure of furosemide and rosuvastatin

For patients, the study adds evidence that some diabetes treatments may not only lower blood sugar, but also reduce the risk of serious heart complications

You may be able to get Wegovy or Mounjaro if: You are 18 or older You have a high BMI (at least 35 kg/m2) + have a health problem like: Type 2 diabetes High blood pressure High cholesterol Sleep problems (like sleep apnoea) Heart disease To be used alongside a reduced-calorie diet and increased physical activity Please note, NHS eligibility for GLP-1 injections is different from the regulatory guidelines mentioned above

[DOI] [PubMed] [Google Scholar] 156.Xu X, Lin L, Chen P, Yu Y, Chen S, Chen X, et al